Female sex | | 10 (21%) | 28 (21%) | 9 (24%) |
Age (years) | | 49 (13) | 48.1 (12) | 50.6 (13) |
HFE
| | | | |
C282Y/C282Y | | 29 (60%) | 87 (66%) | 28 (76%) |
C282Y/H63D | | 3 (6%) | 9 (7%) | 2 (5%) |
C282Y/wt | | 3 (6%) | 4 (3%) | – |
H63D/H63D | | 4 (8%) | 3 (2%) | 1 (3%) |
TfR2 /ferroportin mutations | | – | – | – |
Alcohol misuse | | 8 (17%) | 24 (18%) | 5 (13%) |
Ferritin (ng/ml) | | 1899 (2157) | 1713 (1636) | 1591 (1288) |
Transferrin saturation (%) | | 81 (21) | 77 (21) | 82.6 (18) |
Iron removed to depletion (g) | | 9.4 (7) | 8.5 (6.9) | 8.2 (7.9) |
HCV/HBV chronic hepatitis | | 8 (17%) | 17 (13%) | 3 (8%) |
ALT | | 56 (46 | 61 (59) | 50 (37) |
Liver cirrhosis | | 21 (44%) | 53 (40%) | 18 (49%) |
Diabetes | | 7 (14%) | 26 (20%) | 10 (27%) |
Arthropathy | | 11 (23%) | 25 (21%) | 12 (32%) |
Hypogonadism | | 11 (23%) | 23 (17%) | 8 (22%) |
Cardiomyopathy | | 2* (4%) | 14* (11%) | 11* (30%) |